Vimarsana
Biggest News Aggregation in the World

Page 17 - Research Square News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Research Square. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Research Square Today - Breaking & Trending Today

What factors impacted the adoption of self-management behavior of patients with chronic kidney disease during COVID-19? - Vimarsana News

What factors impacted the adoption of self-management behavior of patients with chronic kidney disease during COVID-19?

Researchers assessed the self-management practices of chronic kidney disease patients during the COVID-19 pandemic.

NQO2 gene as a novel potential target in Parkinson's disease - Vimarsana News

NQO2 gene as a novel potential target in Parkinson's disease

A new study under review at the journal Scientific Reports and currently available on the Research Square* preprint server aimed to analyze the toxic effects of 6OHDA along with a related role of NQO2 in murine and human astrocytes.

Pathogenicity of SARS-CoV-2 viral components on human periodontal tissues and cells - Vimarsana News

Pathogenicity of SARS-CoV-2 viral components on human periodontal tissues and cells

Researchers assessed the impact of COVID-19 on fibrotic pathogenesis via the deregulation of mitochondrial beta-oxidation.

Heart Rate Variability Could Track With Risk for Type 2 Diabetes - Vimarsana News

Heart Rate Variability Could Track With Risk for Type 2 Diabetes

Lower autonomic nervous system function was associated with worse beta-cell function. Could modifying risk factors for neurodegeneration ultimately help prevent and/or slow the onset of type 2 diabetes?

Higher Insulin Resistance Predicts Incident T2D, CKD - Vimarsana News

Higher Insulin Resistance Predicts Incident T2D, CKD

Prospectively collected data from 4314 South Korean adults showed that people with higher levels of insulin resistance have the greatest rate of incident type 2 diabetes and chronic kidney disease.